SENISCA Revenue and Competitors
Estimated Revenue & Valuation
- SENISCA's estimated annual revenue is currently $1.9M per year.
- SENISCA's estimated revenue per employee is $77,500
- SENISCA's total funding is $11M.
Employee Data
- SENISCA has 24 Employees.
- SENISCA grew their employee count by -11% last year.
SENISCA's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer, Co-founder | Reveal Email/Phone |
3 | Founder and CSO | Reveal Email/Phone |
4 | Chief Development Officer | Reveal Email/Phone |
5 | Head Discovery Research | Reveal Email/Phone |
6 | Head Dermatology and Early Preclinical Research | Reveal Email/Phone |
7 | Head Oligotherapeutic Development | Reveal Email/Phone |
8 | VP Dermatology | Reveal Email/Phone |
9 | Commercial and Partnerships Director | Reveal Email/Phone |
10 | Executive Assistant | Reveal Email/Phone |
SENISCA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.9M | 24 | -11% | $10.7M | N/A |
What Is SENISCA?
SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics).Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their genes to rejuvenate aged cells.At SENISCA, we are using this knowledge, concerning how and why cells become senescent, to develop a new generation of oligonucleotide-based interventions, to turn back the ageing clock in old cells and to target the diseases and aesthetic signs of ageing.
keywords:N/A$11M
Total Funding
24
Number of Employees
$1.9M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 24 | -4% | N/A |
#2 | $2.5M | 25 | 25% | N/A |
#3 | $4.5M | 26 | 4% | N/A |
#4 | $2.7M | 26 | -7% | N/A |
#5 | $2.8M | 27 | 93% | N/A |